Skip to main content

Table 3 Characteristics of high-cost and non-high cost MASLD individuals

From: Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort

 

High cost 1444 (10%)

Non-high cost 12,993 (90%)

Sex, n (%)

  

Female

543 (37.6)

3983 (30.7)

Mean age in 2018 (SD)

57.1 (11.2)

52.5 (12)

> 58 years (%)

791 (54.8)

4842 (37.3)

Social Deprivation index, n (%)

  

1st quartile (least deprived)

189 (13.1)

1690 (13)

2nd quartile

234 (16.2)

2247 (17.3)

3rd quartile

285 (19.7)

2553 (19.)

4th quartile

319 (22.1)

3035 (23.4)

5th quartile (most deprived)

417 (28.9)

3468 (26.7)

Educational level, n (%)

  

No diploma

82 (5.7)

539 (4.1)

College, Certificate of primary or secondary education, GCE or A level

598 (41.4)

4092 (31.5)

high school

243 (16.8)

2252 (17.3)

higher education

500 (34.6)

5916 (45.5)

Other

21 (1.5)

194 (1.5)

Charlson Comorbidity Index

1.3 (1.9)

0.7 (1.0)

Comorbidities in 2018, n (%)

  

BMI at inclusion, Mean (SD)

32.6 (5.1)

31.4 (4.4)

> 30 n (%)

951 (65.9)

7426 (57.2)

Waist circumference at inclusion, Mean (SD)

106.6 (10.6)

103.6 (9.4)

Cardio metabolic comorbidities

710 (49.2)

4055 (31.2)

Cardiovascular diseases and stroke

279 (19.3)

757 (5.8)

Mental health disorders

391 (27.1)

1448 (11.1)

Respiratory disease

186 (12.9)

668 (5.1)

Chronic inflammatory disease

120 (8.3)

141 (1.1)

Average length of hospital stay (days), (SD)

5.6 (18)

0.1 (0.5)

  1. SD Standard deviation